MENUNews Archive
Date: 08/04/2021
Researchers led by the University of Michigan Rogel Cancer Center started with a simple thread: an inhibitor that showed promise against metastatic castration-resistant prostate cancer cells. This is the most challenging type of prostate cancer – advanced disease that has become resistant to hormone-based treatment.
Date: 07/30/2021
A new, University of Michigan-led study analyzing data from more than 850 patients across the state of Michigan, however, found a commercially available genomic test known as Decipher Biopsy may help identify patients who are at high risk of prostate cancer progression.
Date: 07/27/2021
As the academic medical center of the University of Michigan, Michigan Medicine was also given the U.S. News & World Report Honor Roll distinction.
Date: 07/23/2021
A $2.26 million grant from the National Cancer Institute lets Christine Veenstra, M.D., MSHP, study the barriers to equitable use of targeted therapies among diverse patients and diverse practice settings.
Date: 07/20/2021
Younger cancer survivors — those between ages 18 and 64 — faced fewer financial barriers to health care after the Affordable Care Act was implemented than they did before the landmark law took effect, University of Michigan researchers found.
Date: 06/30/2021
The Washtenaw County vaccination program has been offering COVID-19 vaccines to our community by partnering with local institutions like to sponsor events.
Date: 06/30/2021
Chemotherapy as additional treatment for breast cancer did not increase the complication rate for women who had a mastectomy and breast reconstruction as part of the same operation.
Date: 06/25/2021
A blood test being developed by Rogel Cancer Center researchers shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment earlier than standard scans.
Date: 06/23/2021
Erika Newman, M.D., has been named the Rogel Cancer Center's first associate director for diversity, equity, inclusion and justice.
Date: 06/23/2021
Leukemia stem cells are rare cells that can renew themselves while continuing to generate malignant cells known as leukemic blasts. These cells are difficult to eradicate using chemotherapy drugs and frequently lead to recurrence of leukemia.